LINEZOLID GENPAR linezolid 600 mg tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

linezolid, Quantity: 600 mg

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

Linezolid

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: povidone; sodium dihydrogen citrate; sodium starch glycollate; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; PEG-40 stearate

Verabreichungsweg:

Oral

Einheiten im Paket:

10, 30

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Linezolid is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,Linezolid is active against Gram-positive bacteria only. Linezolid has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected.

Produktbesonderheiten:

Visual Identification: Off-white, oblong, biconvex, film-coated tablet.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2016-01-28